Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 573236생성일: 2026년 10월 24일
2-(Dicyclohexylphosphino)-2'-methylbiphenyl → N-((4-aminocyclohexyl)methyl)-6-(1H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-amine
https://huagongshe.com/ko/reaction/573236
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-(Dicyclohexylphosphino)-2'-methylbiphenyl | HCID 2734938 | — |
| 반응물 | tert-butyl N-[4-(aminomethyl)cyclohexyl]carbamate | HCID 2756045 | — |
| 반응물 | Sodium t-butoxide | HCID 23676156 | — |
| 반응물 | 3-(6-bromopyridin-2-yl)-1-trityl-1H-pyrazolo[3,4-b]pyridine | HCID 86665933 | — |
| 촉매 | palladium(II) acetate | HCID 167845 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 용매 | 1,2-Dimethoxyethane | HCID 8071 | — |
| 생성물 | N-((4-aminocyclohexyl)methyl)-6-(1H-pyrazolo[3,4-b]pyridin-3-yl)pyridin-2-amine | HCID 178507611 | 31.3% |
반응 단계
To a stirred solution of 3-(6-bromo-2-pyridyl)-1-trityl-pyrazolo[5,4-b]pyridine (100 mg, 0.1933 mmol) and tert-butyl N-[4-(aminomethyl)cyclohexyl]carbamate (52.97 mg, 0.232 mmol) in DME (1.5 mL) was added Palladium acetate (4.340 mg, 0.01933 mmol) followed by dicyclohexyl-[2-(o-tolyl)phenyl]phosphane (7.046 mg, 0.01933 mmol) and sodium t-butoxide (27.87 mg, 0.2900 mmol). The reaction mixture was allowed to stir at 120 degrees in the microwave for 2 hours at which time consumption of the SM was observed. The mixture was diluted with DCM and filtered through a 2.5 g celite cartridge, combined washings were evaporated down to a smaller volume (5 ml) and the resultant solution was cooled to 0 degrees (with the aid of an ice bath) and treated with triethylsilane (0.4 mL, excess) followed by TFA (0.8 mL, excess). The reaction was allowed to stir at 0 degrees for 3 hours at which time LCMS analysis showed presence of product. The mixture was evaporated to dryness, taken up in DMSO and purified by the Fractionlynx system. Relevant fractions were collated together and filtered through a NaHCO3 cartridge to give the free base. The washings were evaporated to dryness, taken up in a small amount of MeCN/water and freeze-dried to give the required product as a white solid (19.5 mg, 31%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09029546B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_05 |
|---|
| ORD ID | ord-88991d3dfa504b7d8f07b44dab14e6bc |
|---|
| 출처 메모 | uspto-grants-2015_05 |
|---|